Breakthrough device designation issued for RightEye’s Parkinson’s assessment system

December 3, 2019
The FDA has granted breakthrough device designation to the RightEye Vision System, an oculomotor test to help diagnose Parkinson’s disease…

In the Journals

Satralizumab reduces relapse in some patients with neuromyelitis optica spectrum disorder

December 2, 2019
Satralizumab added to immunosuppressant treatment may reduce relapse in some cases of neuromyelitis optica spectrum disorder. The phase 3…

Grand Rounds at the New England Eye Center

Man experiences recurrent bilateral optic neuritis

Ocular Surgery News U.S. Edition, November 25, 2019
Alison J. Lauter, MD; Laurel N. Vuong, MD
A 71-year-old man was referred by his usual ophthalmologist to the neuro-ophthalmology clinic at Tufts Medical Center for bilateral decreased vision…

FDA accepts biologics license application for satralizumab

October 31, 2019
The FDA has accepted a biologics license application for satralizumab for the treatment of neuromyelitis optica spectrum disorder, Genentech/Roche…

Ocular Surgery News boosts, relaunches Healio/OSN Editorial Board Section

Ocular Surgery News U.S. Edition, October 10, 2019
Healio.com/OSN is the online home of Ocular Surgery News. In addition to housing the online version of OSN, Healio/OSN creates daily news, meeting…

Satralizumab shows positive phase 3 results for neuromyelitis optica spectrum disorder

September 12, 2019
Satralizumab monotherapy achieved a 55% reduction in the risk for relapses compared with placebo in patients with neuromyelitis optica spectrum…

Grand Rounds at the New England Eye Center

Young woman presents with intermittent diplopia and nausea

Ocular Surgery News U.S. Edition, September 10, 2019
Jarod Santoro, MD; Geetha Athappilly, MD
An 18-year-old woman presented to Lahey Medical Center with 2 weeks of intermittent diplopia, nausea and headache. Two weeks earlier, she had…

New treatments emerging to prevent neuromyelitis optica relapse

Ocular Surgery News U.S. Edition, July 25, 2019
Two new studies have shown promising data supporting the use of eculizumab or satralizumab to significantly reduce the risk for neuromyelitis optica…

FDA approves Alexion’s treatment for neuromyelitis optica spectrum disorder

June 27, 2019
The FDA has announced approval of Soliris injection for treatment of neuromyelitis optica spectrum disorder in adult patients who are…

Meeting News

Reflex tears may provide biomarker for Parkinson’s disease

May 10, 2019
VANCOUVER, British Columbia — Researchers saw changes in oligomeric alpha-synuclein in both basal and reflex tears in patients with…

Meeting News

Retinal changes may reflect dementia progression

May 8, 2019
VANCOUVER, British Columbia — Results of a cross-sectional prospective study showed that several retinal changes were associated with both…

Meeting News

Phase 2a study shows improved vision with stem cell therapy for retinitis pigmentosa

May 1, 2019
VANCOUVER, British Columbia — Human retinal progenitor cell therapy from ReNeuron Group is showing positive preliminary results in the…

Point/Counter

Is there a future for neuroprotection in the treatment of glaucoma?

Ocular Surgery News U.S. Edition, January 10, 2019
Point The clinical trial design to test neuroprotection has improved dramatically recently, and we now have convincing clinical evidence that…

Grand Rounds at the New England Eye Center

Woman presents with bilateral optic nerve edema

Ocular Surgery News U.S. Edition, December 10, 2018
Malgorzata Dymerska, MD; Laurel N. Vuong, MD
A 30-year-old woman was referred to the New England Eye Center neuro-ophthalmology service for evaluation of bilateral optic disc swelling found…

Grand Rounds at the New England Eye Center

Woman with pulmonary lesions presents with ptosis

Ocular Surgery News U.S. Edition, September 10, 2018
Sarah Thornton, MD; Laurel N. Vuong, MD
A 65-year-old woman was referred to the New England Eye Center with a 6-week history of throbbing right brow pain and 4 weeks of progressive right…

The Dry Eye

Trigeminal dysphoria: The ophthalmic highway to hell

Ocular Surgery News U.S. Edition, July 25, 2018
Darrell E. White, MD
Anyone who takes care of patients with dry eye disease has had this experience. A patient comes into the office complaining of severe, life-altering…

Challenges in Ophthalmology with April Steinert

Taking a chance on Botox paid off for Allergan

Ocular Surgery News U.S. Edition, June 10, 2018
April Steinert
Visionary. A word often used to describe prescient leaders, which fits Gavin Herbert Jr., founder of Allergan, perfectly. A friend of presidents…

In the JournalsPerspective

HPV vaccine does not increase risk for autoimmune disease in teen girls

May 30, 2018
The risk for autoimmune disease among teenage girls does not increase after they receive the quadrivalent HPV vaccine, according to findings…

Grand Rounds at the New England Eye Center

Young man presents with vertical diplopia and unilateral ptosis

Ocular Surgery News U.S. Edition, May 25, 2018
Adam T. Chin, MD; Laurel N. Vuong, MD; Thomas R. Hedges III, MD
A 26-year-old man was referred to the neuro-ophthalmology clinic at the New England Eye Center for evaluation of diplopia and ptosis of the left…

Grand Rounds at the New England Eye Center

Woman reports progressive, painless vision loss in left eye

Ocular Surgery News U.S. Edition, April 10, 2018
Sarah Thornton, MD; Nora Muakkassa, MD
A 52-year-old woman presented to the New England Eye Center with a 2-week history of progressive, painless vision loss in the left eye. Her complete…